MedPath
HSA Approval

AMLESSA TABLETS 8 mg/ 5mg

SIN15727P

AMLESSA TABLETS 8 mg/ 5mg

AMLESSA TABLETS 8 mg/ 5mg

June 27, 2019

SINGAPORE PHARMACEUTICAL PRIVATE LIMITED

SINGAPORE PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSINGAPORE PHARMACEUTICAL PRIVATE LIMITED
Licence HolderSINGAPORE PHARMACEUTICAL PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C09BB04

perindopril and amlodipine

Manufacturer Information

SINGAPORE PHARMACEUTICAL PRIVATE LIMITED

Krka, d.d., Novo mesto

Active Ingredients

Perindopril 6.68 mg eqv. to Perindopril tert-Butylamine

8.000mg

Perindopril

Amlodipine besilate 6.935 mg eqv. to amlodipine

5.000mg

Amlodipine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AMLESSA TABLETS 8 mg/ 5mg - HSA Approval | MedPath